BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

791 related articles for article (PubMed ID: 23486940)

  • 21. Misfolded mutant SOD1 directly inhibits VDAC1 conductance in a mouse model of inherited ALS.
    Israelson A; Arbel N; Da Cruz S; Ilieva H; Yamanaka K; Shoshan-Barmatz V; Cleveland DW
    Neuron; 2010 Aug; 67(4):575-87. PubMed ID: 20797535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of astrocytic mitochondrial function by dichloroacetate improves survival and motor performance in inherited amyotrophic lateral sclerosis.
    Miquel E; Cassina A; Martínez-Palma L; Bolatto C; Trías E; Gandelman M; Radi R; Barbeito L; Cassina P
    PLoS One; 2012; 7(4):e34776. PubMed ID: 22509356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased mitochondrial antioxidative activity or decreased oxygen free radical propagation prevent mutant SOD1-mediated motor neuron cell death and increase amyotrophic lateral sclerosis-like transgenic mouse survival.
    Liu R; Li B; Flanagan SW; Oberley LW; Gozal D; Qiu M
    J Neurochem; 2002 Feb; 80(3):488-500. PubMed ID: 11905995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutant SOD1G93A triggers mitochondrial fragmentation in spinal cord motor neurons: neuroprotection by SIRT3 and PGC-1α.
    Song W; Song Y; Kincaid B; Bossy B; Bossy-Wetzel E
    Neurobiol Dis; 2013 Mar; 51():72-81. PubMed ID: 22819776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
    Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
    Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancing NAD+ Salvage Pathway Reverts the Toxicity of Primary Astrocytes Expressing Amyotrophic Lateral Sclerosis-linked Mutant Superoxide Dismutase 1 (SOD1).
    Harlan BA; Pehar M; Sharma DR; Beeson G; Beeson CC; Vargas MR
    J Biol Chem; 2016 May; 291(20):10836-46. PubMed ID: 27002158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epothilone D accelerates disease progression in the SOD1
    Clark JA; Blizzard CA; Breslin MC; Yeaman EJ; Lee KM; Chuckowree JA; Dickson TC
    Neuropathol Appl Neurobiol; 2018 Oct; 44(6):590-605. PubMed ID: 29380402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitochondria in motor nerve terminals: function in health and in mutant superoxide dismutase 1 mouse models of familial ALS.
    Barrett EF; Barrett JN; David G
    J Bioenerg Biomembr; 2011 Dec; 43(6):581-6. PubMed ID: 22089637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The neuroprotective factor Wlds does not attenuate mutant SOD1-mediated motor neuron disease.
    Vande Velde C; Garcia ML; Yin X; Trapp BD; Cleveland DW
    Neuromolecular Med; 2004; 5(3):193-203. PubMed ID: 15626820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
    Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
    Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
    Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic AAV9-mediated suppression of mutant SOD1 slows disease progression and extends survival in models of inherited ALS.
    Foust KD; Salazar DL; Likhite S; Ferraiuolo L; Ditsworth D; Ilieva H; Meyer K; Schmelzer L; Braun L; Cleveland DW; Kaspar BK
    Mol Ther; 2013 Dec; 21(12):2148-59. PubMed ID: 24008656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuronal over-expression of chromogranin A accelerates disease onset in a mouse model of ALS.
    Ezzi SA; Larivière R; Urushitani M; Julien JP
    J Neurochem; 2010 Dec; 115(5):1102-11. PubMed ID: 20807312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adverse effects of a SOD1-peptide immunotherapy on SOD1 G93A mouse slow model of amyotrophic lateral sclerosis.
    Sábado J; Casanovas A; Rodrigo H; Arqué G; Esquerda JE
    Neuroscience; 2015 Dec; 310():38-50. PubMed ID: 26384962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutant superoxide dismutase aggregates from human spinal cord transmit amyotrophic lateral sclerosis.
    Ekhtiari Bidhendi E; Bergh J; Zetterström P; Forsberg K; Pakkenberg B; Andersen PM; Marklund SL; Brännström T
    Acta Neuropathol; 2018 Dec; 136(6):939-953. PubMed ID: 30284034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues.
    Watanabe M; Dykes-Hoberg M; Culotta VC; Price DL; Wong PC; Rothstein JD
    Neurobiol Dis; 2001 Dec; 8(6):933-41. PubMed ID: 11741389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model.
    Dobrowolny G; Giacinti C; Pelosi L; Nicoletti C; Winn N; Barberi L; Molinaro M; Rosenthal N; Musarò A
    J Cell Biol; 2005 Jan; 168(2):193-9. PubMed ID: 15657392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CuZn superoxide dismutase (SOD1) accumulates in vacuolated mitochondria in transgenic mice expressing amyotrophic lateral sclerosis-linked SOD1 mutations.
    Jaarsma D; Rognoni F; van Duijn W; Verspaget HW; Haasdijk ED; Holstege JC
    Acta Neuropathol; 2001 Oct; 102(4):293-305. PubMed ID: 11603803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutant SOD1 in neuronal mitochondria causes toxicity and mitochondrial dynamics abnormalities.
    Magrané J; Hervias I; Henning MS; Damiano M; Kawamata H; Manfredi G
    Hum Mol Genet; 2009 Dec; 18(23):4552-64. PubMed ID: 19779023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coincident thresholds of mutant protein for paralytic disease and protein aggregation caused by restrictively expressed superoxide dismutase cDNA.
    Wang J; Xu G; Slunt HH; Gonzales V; Coonfield M; Fromholt D; Copeland NG; Jenkins NA; Borchelt DR
    Neurobiol Dis; 2005 Dec; 20(3):943-52. PubMed ID: 16046140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.